α7β1 integrin modulator-1

• Description:

  α7β1 integrin modulator-1 is a potent α7β1 integrin modulator. α7β1 integrin modulator-1 has the potential for the research of muscular dystrophy[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319

• Target:

  Integrin

• Type:

  Reference compound

• Related Pathways:

  Cytoskeleton

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/α7β1-integrin-modulator-1.html

• Purity:

  98.02

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=C(CC1=C(OC)C=CC=C1)NC2=CC(S(=O)(N3CCOCC3)=O)=CC=C2N4CCOCC4

• Molecular Formula:

  C23H29N3O6S

• Molecular Weight:

  475.56

• Precautions:

  H302, H315, H319

• References & Citations:

  [1]Dean Burkin, et al. Methods of treating muscular dystrophy. WO2014040077A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  849121-82-0